OB/GYN Clinical Alert articles from June 2005

OB/GYN Clinical Alert archives from June 2005

Is Long-Term Alendronate Treatment a Problem?
June 1, 2005... Is Long-Term Alendronate Treatment a Problem? Abstract & Commentary Leon Speroff, MD, Professor of Obstetrics and Gynecology, Oregon Health Sciences University, Portland, is Editor for OB/Gyn Clinical Alert Odvina and colleagues...

Oral Contraceptives and Stroke Risk.
June 1, 2005... Oral Contraceptives and Stroke Risk Abstract & Commentary Frank W. Ling, MD, WomenEs Health Specialists, PLLC, Memphis, Tennessee, is Associate Editor for OB/Gyn Clinical Alert Synopsis: The risk for stroke among users of low-dose...

Proteomic Profiling in Ovarian Cancer: Is it Plausible?
June 1, 2005... Proteomic Profiling in Ovarian Cancer: Is it Plausible? Abstract & Commentary Robert L. Coleman, MD, Associate Professor, University of Texas; M.D. Anderson Cancer Center, Houston Texas, is Associate Editor for OB/Gyn Clinical Alert...

Alendronate vs Risedronate.
June 1, 2005... Alendronate vs Risedronate Abstract & Commentary Leon Speroff, MD, Professor of Obstetrics and Gynecology, Oregon Health Sciences University, Portland, is Editor for OB/Gyn Clinical Alert Synopsis: Alendronate increased bone...

Exercise and Stress Management Training on Markers of Cardiovascular Risk in Patients with Ischemic Heart Disease.
June 1, 2005... Exercise and Stress Management Training on Markers of Cardiovascular Risk in Patients with Ischemic Heart Disease Abstract & Commentary Sarah L. Berga, MD, James Robert McCord Professor and Chair, Department of Gynecology and...

Special Feature: Primary Spontaneous Intracerebral Hemorrhage.
June 1, 2005... Special Feature Systematic Lymphadenectomy in Ovarian Cancer Surgery: Now We Know! By Robert L. Coleman, MD, Associate Professor, University of Texas; M.D. Anderson Cancer Center, Houston Texas, is Associate Editor for OB/Gyn Clinical...

Pharmacology Watch: Is Nesiritide Associated with a Higher Death Rate?
June 1, 2005... Is Nesiritide Associated with a Higher Death Rate? Pharmacology Watch Nesiritide, Scios' intravenous recombinant form of human B-type naturetic peptide, has been widely used for the treatment of congestive heart failure in hospitalized...

Clinical Briefs in Primary Care supplement.
June 1, 2005... Click here for the June 2005 Clinical Briefs in Primary Care supplement. SOURCE-OB/GYN Clinical Alert

CME Questions.
June 1, 2005... CME Questions The following statements are true regarding bisphosphonates and osteoporosis except: * Bisphosphonates and estrogen are similar in that neither stimulates bone formation. * It is unknown whether a few percentage point...